Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ALLERGAN PHARMACEUTICALS INT LTD [IE]”

21 pharma patents match "ALLERGAN PHARMACEUTICALS INT LTD [IE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 21
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 21 pharmaceutical patents matching "ALLERGAN PHARMACEUTICALS INT LTD [IE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

21 results for “ALLERGAN PHARMACEUTICALS INT LTD [IE]” · 30,257 patents in full index Clear search

  1. US 12383545

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Aug 12, 2025 · Expires Aug 7, 2045

    granted
  2. US 2025064788

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Feb 27, 2025 · Expires Feb 22, 2045

    granted
  3. US 2024180883

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jun 6, 2024 · Expires Jun 1, 2044

    granted
  4. WO 2024081718

    ANTAGONISTE DU RÉCEPTEUR CGRP POUR LE TRAITEMENT DE LA MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Apr 18, 2024 · Expires Apr 13, 2044

    granted
  5. CA 3244873

    TRAITEMENT PRÉVENTIF DE LA MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Sep 14, 2023 · Expires Sep 9, 2043

    granted
  6. US 2023130736

    METHODS OF TREATING MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Apr 27, 2023 · Expires Apr 22, 2043

    granted
  7. US 2022031686

    Treatment of Migraine

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Feb 3, 2022 · Expires Jan 29, 2042

    granted
  8. CA 3177686

    COMPOSITIONS COMPRENANT DE LA TROPOELASTINE RETICULEE A DE L'ACIDE HYALURONIQUE ET LEURS PROCEDES D'UTILISATION

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Nov 18, 2021 · Expires Nov 13, 2041

    granted
  9. CA 3156009

    POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Apr 1, 2021 · Expires Mar 27, 2041

    granted
  10. CA 3152006

    TROPOELASTINE DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA CICATRISATION DE L'ACNE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Mar 4, 2021 · Expires Feb 27, 2041

    granted
  11. WO 2021005494

    ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIALES POUR LE TRAITEMENT DE TROUBLES NEUROPSYCHIATRIQUES ET NEUROLOGIQUES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 14, 2021 · Expires Jan 9, 2041

    granted
  12. WO 2021005493

    ANTAGONISTES DU CGRP ET TOXINES BOTULINIQUES POUR LE TRAITEMENT DE TROUBLES INFLAMMATOIRES ET NEUROLOGIQUES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 14, 2021 · Expires Jan 9, 2041

    granted
  13. WO 2021005497

    ANTAGONISTES DU CGRP ET DÉRIVÉS DE CLOSTRIDIUM POUR LE TRAITEMENT DE TROUBLES ASSOCIÉS À LA DÉPRESSION CORTICALE ENVAHISSANTE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 14, 2021 · Expires Jan 9, 2041

    granted
  14. US 2020345623

    METHODS OF SCAR PREVENTION AND/OR TREATMENT

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Nov 5, 2020 · Expires Oct 31, 2040

    granted
  15. CA 3133787

    GELS HOMOGENES INJECTABLES COMPRENANT DE MULTIPLES FORMES D'ACIDE HYALURONIQUE ET LEURS PROCEDES DE FABRICATION

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Oct 1, 2020 · Expires Sep 26, 2040

    granted
  16. WO 2020012244

    TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AU MOYEN DE BRAZIKUMAB

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 16, 2020 · Expires Jan 11, 2040

    granted
  17. CA 3105778

    POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP ET DES DERIVES DE CLOSTRIDIUM

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 9, 2020 · Expires Jan 4, 2040

    granted
  18. US 2019374520

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Dec 12, 2019 · Expires Dec 7, 2039

    granted
  19. US 2019374518

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Dec 12, 2019 · Expires Dec 7, 2039

    granted
  20. CA 3091946

    EXPANSION ET DIFFERENCIATION DE CELLULES SOUCHES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Sep 6, 2019 · Expires Sep 1, 2039

    granted
  21. WO 2019016609

    TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted